Related Experiment Video
Updated: Dec 8, 2025

10:05
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
Published on: March 20, 2017
12.4K
Erratum to "Maximum Phonation Time in People with Obesity Not Submitted or Submitted to Bariatric Surgery"
Ana Laura Ferreira Fonseca1, Wilson Salgado2, Roberto Oliveira Dantas1
1Department of Medicine, Ribeirão Preto Medical School, University of São Paulo, Av. Bandeirantes 3900 Ribeirão Preto SP, São Paulo 14049-900, Brazil.
Journal of Obesity
|September 21, 2020
Abstract:
[This corrects the article DOI: 10.1155/2019/5903621.].
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
134
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
134
Drug Dosing: Obese Patients
119
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
119
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
96
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
96
Obesity
1.0K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K

